Outlook Therapeutics, Inc. Investor Rights Agreements
9 Contracts & Agreements
- Amended and Restated Investor Rights Agreement, dated April 21, 2022, by and between Outlook Therapeutics, Inc. and GMS Ventures and Investments (Filed With SEC on April 22, 2022)
- Fourth Amendment to Investor Rights Agreement dated September 11, 2017 by and between the Company and BioLexis Pte. Ltd. (formerly GMS Tenshi Holdings Pte. Limited), by and... (Filed With SEC on February 24, 2020)
- Third Amendment to Investor Rights Agreement dated November 5, 2018 (Filed With SEC on November 9, 2018)
- Second Amendment to Investor Rights Agreement, dated July 18, 2018 (Filed With SEC on July 19, 2018)
- Amendment to Investor Rights Agreement dated May 11, 2018 (Filed With SEC on May 15, 2018)
- Investor Rights Agreement by and between Oncobiologics, Inc. and the Investor named therein, dated September 11, 2017 (Filed With SEC on September 11, 2017)
- INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014 (Filed With SEC on May 11, 2016)
- INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014 (Filed With SEC on April 27, 2016)
- INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014 (Filed With SEC on January 15, 2016)
